Zou Yanli, Li Jing Jing, Xue Wei, Kong Xiangbin, Duan Hucheng, Li Yiqun, Wei Lai
Department of Ophthalmology, Affiliated Foshan Hospital, Southern Medical University, Foshan, China.
State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Front Cell Dev Biol. 2021 Nov 18;9:758240. doi: 10.3389/fcell.2021.758240. eCollection 2021.
Uveitis is a sight-threatening intraocular inflammation, and the exact pathogenesis of uveitis is not yet clear. Recent studies, including multiple genome-wide association studies (GWASs), have identified genetic variations associated with the onset and progression of different types of uveitis, such as Vogt-Koyanagi-Harada (VKH) disease and Behcet's disease (BD). However, epigenetic regulation has been shown to play key roles in the immunoregulation of uveitis, and epigenetic therapies are promising treatments for intraocular inflammation. In this review, we summarize recent advances in identifying epigenetic programs that cooperate with the physiology of intraocular immune responses and the pathology of intraocular inflammation. These attempts to understand the epigenetic mechanisms of uveitis may provide hope for the future development of epigenetic therapies for these devastating intraocular inflammatory conditions.
葡萄膜炎是一种威胁视力的眼内炎症,其确切发病机制尚不清楚。包括多项全基因组关联研究(GWAS)在内的近期研究已经确定了与不同类型葡萄膜炎(如伏格特-小柳-原田病(VKH)和白塞病(BD))的发病和进展相关的基因变异。然而,表观遗传调控已被证明在葡萄膜炎的免疫调节中起关键作用,表观遗传疗法是治疗眼内炎症的有前景的方法。在这篇综述中,我们总结了在确定与眼内免疫反应生理学和眼内炎症病理学相互作用的表观遗传程序方面的最新进展。这些对理解葡萄膜炎表观遗传机制的尝试可能为这些破坏性眼内炎症性疾病的表观遗传疗法的未来发展带来希望。